(Q35568749)

8 August 2017

1 reference

title

Secondary hyperparathyroidism in children with chronic renal failure: pathogenesis and treatment (English)

1 reference

secondary hyperparathyroidism

8 August 2017

1 reference

1 reference

Cheryl P Sanchez

1

1 reference

8 August 2017

publication date

1 January 2003

1 reference

8 August 2017

1 reference

8 August 2017

volume

5

1 reference

8 August 2017

issue

11

1 reference

8 August 2017

page(s)

763-776

1 reference

https://scigraph.springernature.com/pub.10.2165/00148581-200305110-00005

8 August 2017

exact match

0 references

cites work

Renal osteodystrophy in children undergoing continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism

1 reference

12 December 2020

PTH/PTHrP receptor mRNA is down-regulated in epiphyseal cartilage growth plate of uraemic rats

1 reference

12 December 2020

PTH 1-84 and PTH "7-84" in the noninvasive diagnosis of renal bone disease

1 reference

12 December 2020

Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD

1 reference

12 December 2020

Comparison of treatments for mild secondary hyperparathyroidism in hemodialysis patients. Durham Renal Osteodystrophy Study Group

1 reference

12 December 2020

The Treatment of Uraemic Hyperphosphataemia with Calcium Acetate and Calcium Carbonate: A Comparative Study

1 reference

12 December 2020

Reduced plasma concentration of 1,25-dihydroxyvitamin D in children with moderate renal insufficiency

1 reference

12 December 2020

25-hydroxyvitamin D3 (calcifediol) therapy of juvenile renal osteodystrophy: beneficial effect on linear growth velocity

1 reference

12 December 2020

RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group

1 reference

12 December 2020

Histologic and dynamic changes induced by chronic metabolic acidosis in the rat growth plate

1 reference

12 December 2020

Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure

1 reference

12 December 2020

RNA-Protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate

1 reference

12 December 2020

A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure

1 reference

12 December 2020

Administration of PTH-(7-84) antagonizes the effects of PTH-(1-84) on bone in rats with moderate renal failure

1 reference

12 December 2020

Skeletal Changes and Growth in Experimental Uremia

1 reference

12 December 2020

Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure

1 reference

12 December 2020

Growth of long bones in renal failure: roles of hyperparathyroidism, growth hormone and calcitriol

1 reference

12 December 2020

New phosphate binding agents: ferric compounds

1 reference

12 December 2020

Effect of high extracellular phosphate concentration on arachidonic acid production by parathyroid tissue in vitro

1 reference

12 December 2020

Citrate: a major factor in the toxicity of orally administered aluminum compounds

1 reference

12 December 2020

Prevalence and clinical consequences of elevated Ca x P product in hemodialysis patients.

1 reference

12 December 2020

19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis

1 reference

12 December 2020

Renal osteodystrophy in children undergoing continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Chronic dialysis in children and adolescents. The 2001 NAPRTCS Annual Report.

1 reference

12 December 2020

Calcitriol pulse therapy is not more effective than daily calcitriol therapy in controlling secondary hyperparathyroidism in children with chronic renal failure. European Study Group on Vitamin D in Children with Renal Failure

1 reference

12 December 2020

Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis

1 reference

12 December 2020

Treatment of secondary hyperparathyroidism of predialysis chronic renal failure with low doses of 1,25(OH)2D3: humoral and histomorphometric results

1 reference

12 December 2020

Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management

1 reference

12 December 2020

Growth in children with chronic renal failure on intermittent versus daily calcitriol

1 reference

12 December 2020

Diagnosis of aluminum-related bone disease and treatment of aluminum toxicity with deferoxamine

1 reference

12 December 2020

Intermittent administration of parathyroid hormone (1-37) improves growth and bone mineral density in uremic rats

1 reference

12 December 2020

Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis

1 reference

12 December 2020

Treatment of childhood renal osteodystrophy with calcitriol or ergocalciferol

1 reference

12 December 2020

Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia

1 reference

12 December 2020

Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo

1 reference

12 December 2020

Increased Growth after Long-Term Oral 1α,25-Vitamin D3in Childhood Renal Osteodystrophy

1 reference

12 December 2020

Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patients.

1 reference

12 December 2020

1,25(OH)2D3 administration in moderate renal failure: a prospective double-blind trial

1 reference

12 December 2020

Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color Doppler flow mapping in chronic dialysis patients

1 reference

12 December 2020

Insulin-like growth factor-I gene expression in the tibial epiphyseal growth plate of growth hormone-treated uremic rats.

1 reference

12 December 2020

The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism

1 reference

12 December 2020

Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure

1 reference

12 December 2020

Bone and mineral metabolism in childhood end-stage renal disease.

1 reference

12 December 2020

Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency

1 reference

12 December 2020

Influence of PTH assay methodology on differential diagnosis of renal bone disease.

1 reference

12 December 2020

The use of alfacalcidol in the prevention of bone disease in early renal failure

1 reference

12 December 2020

Effect of 22-oxacalcitriol on bone histology of hemodialyzed patients with severe secondary hyperparathyroidism

1 reference

12 December 2020

Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD

1 reference

12 December 2020

Effect of low dose 1 alpha-hydroxycholecalciferol on glomerular filtration rate in moderate renal failure

1 reference

12 December 2020

Action of 1alpha-hydroxy vitamin D3 on calcium absorption and bone resorption in man

1 reference

12 December 2020

Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.

1 reference

12 December 2020

Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients

1 reference

12 December 2020

Calcium carbonate is an effective phosphorus binder in children with chronic renal failure

1 reference

12 December 2020

Effects of 1,25-dihydroxy-22-oxavitamin D(3) on parathyroid gland function in haemodialysis patients with secondary hyperparathyroidism

1 reference

12 December 2020

Parenteral calcitriol for treatment of severe renal osteodystrophy in children with chronic renal insufficiency

1 reference

12 December 2020

Expression and signal transduction of calcium-sensing receptors in cartilage and bone

1 reference

12 December 2020

Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzed uremic patients treated with long-term intravenous calcitriol

1 reference

12 December 2020

Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD.

1 reference

12 December 2020

Parathyroid function in mild to moderate renal failure: evaluation by oral calcium suppression test

1 reference

12 December 2020

Poly[allylamine hydrochloride] (RenaGel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure

1 reference

12 December 2020

Vitamin D replacement therapy and renal function. Calcitriol v dihydrotachysterol

1 reference

12 December 2020

Direct in vivo assessment of parathyroid hormone-calcium relationship curve in renal patients

1 reference

12 December 2020

A controlled trial of the early treatment of secondary hyperparathyroidism with calcitriol in hemodialysis patients

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia

1 reference

12 December 2020

The role of metabolic acidosis in causing uremic hyperphosphatemia

1 reference

12 December 2020

1 alpha-hydroxy vitamin D3 treatment of non-dialyzed patients with chronic renal failure. Effects on bone, mineral metabolism and kidney function

1 reference

12 December 2020

Effective suppression of parathyroid hormone by 1 alpha-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism

1 reference

12 December 2020

Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro

1 reference

12 December 2020

Renal bone disease 1990: an unmet challenge for the nephrologist

1 reference

12 December 2020

Correction of acidosis in hemodialysis patients increases the sensitivity of the parathyroid glands to calcium

1 reference

12 December 2020

Effect of phosphate on parathyroid hormone secretion in vivo.

1 reference

12 December 2020

Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients

1 reference

12 December 2020

1,25-dihydroxyvitamin D3 and 22-oxacalcitriol prevent the decrease in vitamin D receptor content in the parathyroid glands of uremic rats

1 reference

12 December 2020

Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D.

1 reference

12 December 2020

Chronic renal insufficiency in children and adolescents: the 1996 annual report of NAPRTCS. North American Pediatric Renal Transplant Cooperative Study.

1 reference

12 December 2020

Controlled trial of 1apha-hydroxycholecalciferol in chronic renal failure

1 reference

12 December 2020

Effects of 25-hydroxycholecalciferol on bone lesions of children with terminal renal failure

1 reference

12 December 2020

Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism

1 reference

12 December 2020

Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure.

1 reference

12 December 2020

Morphometry of uremic rat growth plate.

1 reference

12 December 2020

Direct in vivo comparison of calcium-regulated parathyroid hormone secretion in normal volunteers and patients with secondary hyperparathyroidism

1 reference

12 December 2020

Bone biochemistry and physiology from the perspectives of the vitamin D endocrine system

1 reference

12 December 2020

Daily intermittent decreases in serum levels of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalacia

1 reference

12 December 2020

Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol

1 reference

12 December 2020

Calcitriol and calcium carbonate therapy in early chronic renal failure.

1 reference

12 December 2020

Effects of dietary phosphate restriction in children with chronic renal failure

1 reference

12 December 2020

Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial

1 reference

12 December 2020

Safety and efficacy of pulse and daily calcitriol in patients on CAPD: a randomized trial

1 reference

12 December 2020

Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients

1 reference

12 December 2020

The effects of intraperitoneal calcitriol on calcium and parathyroid hormone

1 reference

12 December 2020

Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure

1 reference

12 December 2020

Low-dose calcitriol prevents the rise in 1,84-iPTH without affecting serum calcium and phosphate in patients with moderate renal failure (prospective placebo-controlled multicentre trial)

1 reference

12 December 2020

Bone histology in incipient and advanced renal failure

1 reference

12 December 2020

Hyperparathyroidism and 1,25-Dihydroxyvitamin D Deficiency in Mild, Moderate, and Severe Renal Failure*

1 reference

12 December 2020

1 reference

12 December 2020

Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis

1 reference

12 December 2020

Comparisons between oral and intraperitoneal 1,25-dihydroxyvitamin D3 therapy in children treated with peritoneal dialysis

1 reference

12 December 2020

Low dose calcitriol versus placebo in patients with predialysis chronic renal failure

1 reference

12 December 2020

Direct effect of the correction of acidosis on plasma parathyroid hormone concentrations, calcium and phosphate in hemodialysis patients: a prospective study

1 reference

12 December 2020

Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease

1 reference

12 December 2020

Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid

1 reference

12 December 2020

Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure

1 reference

12 December 2020

Pathogenesis of secondary hyperparathyroidism

1 reference

12 December 2020

Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis

1 reference

12 December 2020

Hyperparathyroid bone disease in children undergoing long-term hemodialysis; treatment with vitamin D

1 reference

12 December 2020

Stabilized polynuclear iron hydroxide is an efficient oral phosphate binder in uraemic patients.

1 reference

12 December 2020

A novel mechanism for skeletal resistance in uremia

1 reference

12 December 2020

Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD

1 reference

12 December 2020

Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure

1 reference

12 December 2020

Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration

1 reference

12 December 2020

Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy

1 reference

12 December 2020

Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism

1 reference

12 December 2020

Treatment of secondary hyperparathyroidism in hemodialyzed patients with high-dose calcium carbonate without vitamin D3 supplements

1 reference

12 December 2020

Magnesium carbonate as a phosphorus binder: a prospective, controlled, crossover study

1 reference

12 December 2020

Reversal of secondary hyperparathyroidism by phosphate restriction restores parathyroid calcium-sensing receptor expression and function.

1 reference

12 December 2020

Renal osteodystrophy in children with chronic renal failure: an unexpectedly common and incapactating complication

1 reference

12 December 2020

A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia

1 reference

12 December 2020

A deficit of calcitriol synthesis may not be the initial factor in the pathogenesis of secondary hyperparathyroidism

1 reference

12 December 2020

Molecular cloning and hormonal regulation of PiT-1, a sodium-dependent phosphate cotransporter from rat parathyroid glands

1 reference

12 December 2020

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients

1 reference

12 December 2020

Net calcium efflux from live bone during chronic metabolic, but not respiratory, acidosis

1 reference

12 December 2020

Is 1,25-dihydroxy-cholecalciferol harmful to renal function in patients with chronic renal failure?

1 reference

12 December 2020

10.2165/00148581-200305110-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

8 August 2017

1042033862

0 references

1 reference